Clinical trial
A Prospective Clinical Study to Evaluate a Novel Non-invasive Prenatal Screening Method for Characterizing Fetal Whole Chromosome Aberrations and Other Major Defects and Deletions Found in the Maternal Blood.
NCT02317965 is registered in ClinicalTrials.gov with Progenity, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Clinical Study to Evaluate a Novel Non-invasive Prenatal Screening Method for Characterizing Fetal Whole Chromosome Aberrations and Other Major Defects and Deletions Found in the Maternal Blood.
- Lead sponsor
- Progenity, Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2015
- Completion date
- November 30, 2018
- Enrollment
- 340 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
down syndrome, edwards syndrome